Outset Medical, Inc. Comprehensive Income
Outset Medical, Inc. (OM) reported Comprehensive Income of -$18.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06
- Outset Medical, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$18.05M.
- Outset Medical, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$19.22M.
- Outset Medical, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$19.48M.
- Outset Medical, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$17.73M.
- Outset Medical, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$81.52M.
- Outset Medical, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$128.00M.
- Outset Medical, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$172.16M.
- Outset Medical, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$163.34M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$18.05M 10-Q · filed 2026-08-06 | -$37.27M 10-Q · filed 2026-08-06 | -$56.75M derived: sum of 3 quarters · filed 2026-08-06 | -$74.48M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$19.22M 10-Q · filed 2026-05-07 | -$38.70M derived: sum of 2 quarters · filed 2026-05-07 | -$56.43M derived: sum of 3 quarters · filed 2026-05-07 | -$75.01M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$19.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$37.21M derived: sum of 2 quarters · filed 2026-02-13 | -$55.79M derived: sum of 3 quarters · filed 2026-08-06 | -$81.52M 10-K · filed 2026-02-13 |
| 2025-09-30 | -$17.73M 10-Q · filed 2025-11-10 | -$36.31M derived: sum of 2 quarters · filed 2026-08-06 | -$62.05M 10-Q · filed 2025-11-10 | -$88.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$18.58M 10-Q · filed 2026-08-06 | -$44.32M 10-Q · filed 2026-08-06 | -$70.27M derived: sum of 3 quarters · filed 2026-08-06 | -$97.55M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$25.74M 10-Q · filed 2026-05-07 | -$51.69M derived: sum of 2 quarters · filed 2026-05-07 | -$78.97M derived: sum of 3 quarters · filed 2026-05-07 | -$113.47M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$25.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$53.23M derived: sum of 2 quarters · filed 2026-02-13 | -$87.73M derived: sum of 3 quarters · filed 2026-02-13 | -$128.00M 10-K · filed 2026-02-13 |
| 2024-09-30 | -$27.29M 10-Q · filed 2025-11-10 | -$61.78M derived: sum of 2 quarters · filed 2025-11-10 | -$102.05M 10-Q · filed 2025-11-10 | -$140.33M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | -$34.50M 10-Q · filed 2025-08-07 | -$74.77M 10-Q · filed 2025-08-07 | -$113.05M derived: sum of 3 quarters · filed 2026-02-13 | -$159.09M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | -$40.27M 10-Q · filed 2025-05-08 | -$78.55M derived: sum of 2 quarters · filed 2026-02-13 | -$124.59M derived: sum of 3 quarters · filed 2026-02-13 | -$168.91M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | -$38.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$84.32M derived: sum of 2 quarters · filed 2026-02-13 | -$128.65M derived: sum of 3 quarters · filed 2026-02-13 | -$172.16M 10-K · filed 2026-02-13 |
| 2023-09-30 | -$46.04M 10-Q · filed 2024-11-07 | -$90.37M derived: sum of 2 quarters · filed 2024-11-07 | -$133.89M 10-Q · filed 2024-11-07 | -$174.96M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$44.33M 10-Q · filed 2024-08-08 | -$87.85M 10-Q · filed 2024-08-08 | -$128.92M derived: sum of 3 quarters · filed 2025-02-28 | -$169.68M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$43.52M 10-Q · filed 2024-05-09 | -$84.59M derived: sum of 2 quarters · filed 2025-02-28 | -$125.35M derived: sum of 3 quarters · filed 2025-02-28 | -$169.50M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$41.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$81.83M derived: sum of 2 quarters · filed 2025-02-28 | -$125.98M derived: sum of 3 quarters · filed 2025-02-28 | -$163.34M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$40.76M 10-Q · filed 2023-11-08 | -$84.91M derived: sum of 2 quarters · filed 2023-11-08 | -$122.26M 10-Q · filed 2023-11-08 | -$163.66M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | -$44.15M 10-Q · filed 2023-08-03 | -$81.50M 10-Q · filed 2023-08-03 | -$122.90M derived: sum of 3 quarters · filed 2024-02-21 | -$153.36M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | -$37.36M 10-Q · filed 2023-05-04 | -$78.75M derived: sum of 2 quarters · filed 2024-02-21 | -$109.22M derived: sum of 3 quarters · filed 2024-02-21 | -$139.44M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | -$41.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$71.86M derived: sum of 2 quarters · filed 2024-02-21 | -$102.09M derived: sum of 3 quarters · filed 2024-02-21 | -$132.12M 10-K · filed 2024-02-21 |
| 2021-09-30 | -$30.46M 10-Q · filed 2022-11-09 | -$60.69M derived: sum of 2 quarters · filed 2022-11-09 | -$90.72M 10-Q · filed 2022-11-09 | -$122.77M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | -$30.23M 10-Q · filed 2022-08-02 | -$60.26M 10-Q · filed 2022-08-02 | -$92.31M derived: sum of 3 quarters · filed 2023-02-13 | -$134.60M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | -$30.03M 10-Q · filed 2022-05-05 | -$62.08M derived: sum of 2 quarters · filed 2023-02-13 | -$104.37M derived: sum of 3 quarters · filed 2023-02-13 | -$130.86M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | -$32.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | -$74.34M derived: sum of 2 quarters · filed 2023-02-13 | -$100.83M derived: sum of 3 quarters · filed 2023-02-13 | -$121.51M 10-K · filed 2023-02-13 |
| 2020-09-30 | -$42.29M 10-Q · filed 2021-11-04 | -$68.78M derived: sum of 2 quarters · filed 2021-11-04 | -$89.47M 10-Q · filed 2021-11-04 | -$108.94M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | -$26.49M 10-Q · filed 2021-08-06 | -$47.18M 10-Q · filed 2021-08-06 | -$66.64M derived: sum of 3 quarters · filed 2022-02-23 | -$82.05M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | -$20.68M 10-Q · filed 2021-05-06 | -$40.15M derived: sum of 2 quarters · filed 2022-02-23 | -$55.56M derived: sum of 3 quarters · filed 2022-02-23 | |
| 2019-12-31 | -$19.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$34.88M derived: sum of 2 quarters · filed 2022-02-23 | -$68.22M 10-K · filed 2022-02-23 | |
| 2019-09-30 | -$15.41M 10-Q · filed 2020-11-12 | -$48.75M 10-Q · filed 2020-11-12 | ||
| 2018-12-31 | -$49.82M 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |